ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,721.60
-1.06%
S&P ASX All Technology
3,063.30
-0.61%
Brent Oil
83.715
0.19%
US Dollar vs AUD
1.52185
0.09%
Bitcoin
61,613.89
0.70%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. 60 Degrees Pharmaceuticals Inc (SXTPW)

  7. 60 Degrees Pharmaceuticals Inc (SXTPW) News

SXTPW 60 Degrees Pharmaceuticals Inc

0.105
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
60 Degrees Pharmaceuticals Inc SXTPW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 0.105 07:09:09
Open Price Low Price High Price Close Price Previous Close
0.1061 0.1061 0.1061 0.105 0.105
more quote information »

Recent News

Date Time Source Heading
08/5/202421:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
02/5/202421:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
03/4/202422:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
14/3/202422:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
20/2/202423:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
08/2/202423:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
01/2/202403:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
31/1/202401:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
22/1/202423:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
16/1/202423:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
26/12/202323:59GLOBE60 Degrees Pharma Announces IRB Approval of Phase IIA Study..
15/11/202323:29GLOBE60 Degrees Pharma Announces Type C Meeting with FDA to..
19/10/202323:31GLOBE60 Degrees Pharma to Present Review of Safety, Efficacy Data..
13/10/202307:16GLOBE60 Degrees Pharmaceuticals Suspends Phase IIB Study of..
19/9/202306:16GLOBE60 Degrees Pharma Withdraws COVID Phase IIB IND, Will..
06/9/202321:31GLOBE60 Degrees Pharmaceuticals to Participate in H.C. Wainwright..
30/8/202321:32GLOBE60 Degrees Pharmaceuticals Study Results Published by New..
22/8/202321:31GLOBE60 Degrees Pharmaceuticals Receives Additional U.S. Patent..
15/8/202321:31GLOBE60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB..
31/7/202321:59GLOBE60 Degrees Pharmaceuticals Awarded Canadian Patent Covering..
15/7/202302:39GLOBE60 Degrees Pharmaceuticals Announces Closing of Initial..
13/7/202302:29GLOBE60 Degrees Pharmaceuticals Announces Pricing of Initial..

Your Recent History

NASDAQ
SXTPW
60 Degrees Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved